We are live on
!
Find out more
OCM
Oakview Capital Management Portfolio holdings
AUM
$21.6M
1-Year Est. Return
20.25%
This Fund
S&P 500
This Quarter
Est. Return
0%
1 Year Est. Return
+20.25%
3 Year Est. Return
+21.24%
5 Year Est. Return
+60.68%
10 Year Est. Return
–
AUM
$201M
AUM Growth
-$9.96M
(-4.7%)
Cap. Flow
-$9.96M
Cap. Flow
% of AUM
-4.97%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
48
New
1
Increased
–
Reduced
–
Closed
46
Top Buys
No buys this quarter
Top Sells
| 1 |
FMC
FMC
|
+$22.5M |
| 2 |
Pfizer
PFE
|
+$20.8M |
| 3 |
Orthofix Medical
OFIX
|
+$19.5M |
| 4 |
NetApp
NTAP
|
+$18.5M |
| 5 |
General Motors
GM
|
+$18.2M |
Sector Composition
| 1 | Communication Services | 0% |
| 2 | Consumer Discretionary | 0% |
| 3 | Consumer Staples | 0% |
| 4 | Energy | 0% |
| 5 | Financials | 0% |
Similar funds
KLM
SRCM
CMG
TM
A
WA
LC
TOTSC
Oakview Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Oakview Capital Management held 48 positions worth $201M, down 4.7% from $211M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Oakview Capital Management withdrew a net $9.96M in Q2 2017, closing 46 positions. Its most notable exit was FMC, an estimated $22.5M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 0% of assets, down from 8.4% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
- Oakview Capital Management fully exited FMC in Q2 2017, selling an estimated $22.5M.
- Oakview Capital Management's ten largest holdings make up 100% of its $201M portfolio in Q2 2017.
- Oakview Capital Management opened 1 new position and closed 46 in Q2 2017.
- Oakview Capital Management's portfolio value fell 4.7% quarter-over-quarter to $201M.
Based on Oakview Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.